[ET Net News Agency, 28 November 2022] HANSOH PHARMA (03692) fell 3.02% to HK$13.5.
It hits an intra-day low of HK$13.5, and an intra-day high of HK$13.72. The total shares
traded was 484,000, with a value of HK$6.58m. The active buy/sell ratio is 56:44, with net
buying turnover of HK$737,480. CITIGROUP GLOBAL accounts for greatest net responsive
buying turnover of HK$387,245, with volume weighted average price of HK$13.619. BARCLAYS
CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$180,255, with
volume weighted average price of HK$13.594. The stock has fallen a combined 4.8% over the
past 2 consecutive trading days.
The Hang Seng Index now fell 707 points, or 4.03% to 16,866; the Hang Seng China
Enterprises Index now fell 258 points, or 4.33% to 5,712; the Hang Seng TECH Index now
fell 157 points, or 4.51% to 3,342; with an overall turnover of HK$24.06b.
The SSE Composite Index now fell 66 points, or 2.15% to 3,035, with an overall turnover
of RMB86.3b.
The SZSE Component Index now fell 244 points, or 2.24% to 10,660, with an overall
turnover of RMB44.69b.
Basic Information
=================
----------------------------------
Nominal 13.500 % Chg -3.02%
High 13.720 Low 13.500
Shares Tr 484,000 Turnover 6.58m
10-D SMA 14.462 %H.V 59.949
20-D SMA 14.091 VWAP 13.604
50-D SMA 13.192 RSI14 45.954
----------------------------------
Status: Active buy/sell ratio is 56:44, with net buying turnover of HK$737,480, falling a
combined 4.8% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
HANSOH PHARMA (03692) 13.50 -3.02
ALI HEALTH (00241) 5.36 -3.77
SINO BIOPHARM (01177) 4.10 -3.30
INNOVENT BIO (01801) 27.00 -3.57
JXR (01951) 5.23 +2.15
FOSUN PHARMA (02196) 23.80 -1.65
WUXI BIO (02269) 45.30 -5.13
CANSINOBIO (06185) 96.20 -2.04
JD HEALTH (06618) 60.40 -5.18
AKESO-B (09926) 30.95 -1.75
---------------------------------------------
(ed)